Inventiva (IVEVF) Net Cash Flow (2019 - 2025)
Inventiva (IVEVF) posted Net Cash Flow of $93.6 million for Q2 2025, up 279.71% on a QoQ basis from -$52.1 million in Q2 2024, and up 279.71% year-over-year from $24.6 million in Q2 2024.
Analysis
Inventiva (IVEVF) Net Cash Flow (2019 - 2025) Analysis & Trends
Inventiva has reported Net Cash Flow for 6 years, with the latest figure at $93.6 million in Q2 2025.
- On a quarterly basis, Net Cash Flow rose 279.71% year-over-year to $93.6 million in Q2 2025; TTM through Jun 2025 was $15.6 million, a 116.43% increase from a year earlier, with the FY2025 full-year figure at $3.7 million, down 94.88% from the prior year.
- Net Cash Flow was $93.6 million for Q2 2025 at Inventiva, up from -$52.1 million in the prior quarter.
- The five-year high for Net Cash Flow was $93.6 million in Q2 2025, with the low at -$52.1 million in Q2 2024.
- Average Net Cash Flow over 4 years is -$2.8 million, with a median of -$13.1 million recorded in 2022.
- The sharpest annual moves came in 2021 and 2025: Net Cash Flow slumped 393.93% in 2021, then soared 279.71% in 2025.
- Over 4 years, Net Cash Flow stood at -$17.2 million in 2021, then rose by 25.56% to -$12.8 million in 2022, then sank by 307.0% to -$52.1 million in 2024, then jumped by 279.71% to $93.6 million in 2025.
- The last three Net Cash Flow figures came in at $93.6 million (Q2 2025), -$52.1 million (Q2 2024), and -$12.8 million (Q4 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.04 Bn | 624.28 Bn | 17.26 Bn | -1.27 Bn |
| 2 | AbbVie | 440.25 Bn | 433.68 Bn | 12.70 Bn | -2.82 Bn |
| 3 | Merck | 365.65 Bn | 358.51 Bn | 12.21 Bn | 1.53 Bn |
| 4 | Novartis Ag | 266.64 Bn | 258.95 Bn | 11.24 Bn | 757.00 Mn |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn | -722.00 Mn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 918.27 Mn |
| 7 | Revolution Medicines | 44.19 Bn | 44.19 Bn | - | 374.50 Mn |
| 8 | Incyte | 25.29 Bn | 20.75 Bn | 1.57 Bn | 521.33 Mn |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn | 523.50 Mn |
| 10 | Inventiva | 693.72 Mn | 693.72 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 93.56 Mn |
| Jun 30, 2024 | -52.06 Mn |
| Dec 31, 2022 | -12.79 Mn |
| Sep 22, 2022 | -13.08 Mn |
| Dec 31, 2021 | -17.18 Mn |
| Jun 30, 2021 | -20.66 Mn |
| Mar 31, 2021 | 2.58 Mn |
| Dec 31, 2020 | 19.59 Mn |
| Jun 30, 2020 | 7.03 Mn |
| Mar 31, 2020 | 12.20 Mn |
| Dec 31, 2019 | -21.72 Mn |